Status: Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well
SELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving better functional outcomes (measured using modified Rankin Scale Scores) at 90-day follow-up (± 15 days).
Participants needed: 408
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Amrou SarrajUpdated: Jul 6, 2026Locations: 6
Eligibility criteria
Adults (18-85* years) with the final diagnosis of an acute ischemic stroke$ [+7]
Current participation in another investigational interventional drug or device s... [+12]